Organic compounds -- part of the class 532-570 series – Organic compounds – Oxygen containing
Reexamination Certificate
2008-05-08
2011-12-06
Witherspoon, Sikarl (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Oxygen containing
C568S778000, C568S780000, C514S731000, C514S737000
Reexamination Certificate
active
08071818
ABSTRACT:
A (−)-stereoisomer of formula (I): [insert formula (I) wherein X is H or F; or a pharmaceutically acceptable salt or prodrug thereof, useful as an anesthetic.
REFERENCES:
patent: 2747982 (1956-05-01), Mussell et al.
patent: 4056635 (1977-11-01), Glen et al.
patent: 4452817 (1984-06-01), Glen et al.
patent: 4798846 (1989-01-01), Glen et al.
patent: 5714520 (1998-02-01), Jones et al.
patent: 5731355 (1998-03-01), Jones et al.
patent: 5908869 (1999-06-01), Jones et al.
patent: 6140374 (2000-10-01), May et al.
patent: 7731356 (2010-06-01), Gilbert
patent: 2006033911 (2006-03-01), None
Voss, Guenther, Substituted phenyl N-methylcarbamate. Cholinesterase inhibition and insecticidal activity. Anzeiger fuer Schaedlingskunde, 1967, vol. 40 (5), 73-77. HCAPLUS document No. 67:81442; Accession No. 1967:481442.
James, et al. Synthesis, Biological Evaluation, and Preliminary Structure-Activity Considerations of a Series of Alkylphenols as Intravenous Anesthetic Agents. J. Med. Chem. 1980, 23, 1350-1357.
Krasowski, et al. General Anesthetic Potencies of a Series of Propofol Analogs Correlate with Potency for Potentiation of gamma-Aminobutyric Acid (GABA) Current at the GABA-A receptor but Not with Lipid Solubility. Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, US, vol. 297, No. 1, (2001), pp. 338-351.
Maciagiewicz, et al. Design and synthesis of propofol analogs as new anesthetic agents. Abstracts of Papers, 233rd ACS National Meeting, Chicago, IL, United States, Mar. 25-29, 2007 (2002).
Altomare et al., “Highly Water-Soluble Derivatives of the Anesthetic Agent Propofol: In Vitro and In Vivo Evaluation of Cyclic Amino Acid Esters” Eur J Pharm Sci., vol. 20, (2003), p. 17-26.
Concas et al. “The General Anesthetic Propofol Enhances the Function of Gamma-Aminobutyric Acid-Coupled Chloride Channel in the Rat Cerebral Cortex” Journal of neurochemistry, vol. 55 (1990), p. 2135-2138.
Concas et al., “Neurochemical Action of the General Anaesthetic Propofol on the Chloride Ion Channel Coupled with GABAA Receptors” BRES, vol. 16356, (1990), p. 225-232.
Fechner et al. “Comparative Pharmacokinetics and Pharmacodynamics of the New Propofol Prodrug GPI 15715 and Propofol Emulsion” Anesthesiology, vol. 101, (2004), p. 626-639.
Fechner et al. “Pharmacokinetics and Clinical Pharmacodynamics of the New Propofol Prodrug GPI 15715 in Volunteers” Anesthesiology, vol. 99 (2003), p. 303-313.
Fechner et al. “Sedation with GPI 15715, a Water-Soluble Prodrug of Propofol, Using Target-Controlled Infusion in Volunteers” Anesthesia and Analgesia, vol. 100, (2005), p. 701-706.
Jian Qiu et al. “2,6-Difluorophenol as a Bioisostere of a Carboxylic Acid: Bioisosteric Analogues of y-Aminobutyric Acid” J. Med. Chem., vol. 42, (1999), p. 329-332.
Sagara et al. “Propofol Hemisuccinate Protects Neuronal Cells From Oxidative Injury” J Neurochem., vol. 73(6), (1999), p. 2524-2530.
Sanna E et al. “Novel Properties of Homomeric,81 -y-Aminobutyric Acid Type A Receptors: Actions of the Anesthetics Propofol and Pentobarbital” Molecular Pharmacology, vol. 47, (1995), p. 213-217.
Sneyd, J.R. “Recent Advances in Intravenous Anaesthesia” Br J Anaesth, vol. 93, (2004), p. 725-736.
Struys et al. “AQUAVAN Injection, a Water-Soluble Prodrug of Propofol, as a Bolus Injection: a Phase I dose-Escalation Comparison with DIPRIVAN (part 2): Pharmacodynamics and Safety” Anesthesiology, vol. 103, (2005), p. 730-743.
Tan, et al. “Pain on Injection of Propofol” Anaesthesia, vol. 53, (1998) p. 468-476.
Thompson Sally-Anne et al. “Mechanism of Action of General Anaesthetics New Information from Molecular Pharmacology” Current Opinion in Pharmaologym, vol. 1 (2001), p. 78-83.
Tomlin, S.L..et al. “Stereoselective Effects of Etomidate Optical Isomers on Gamma Aminobutyric Acid Type A Receptors and Animals” Anesthesiology, vol. 88, (1998), p. 708-717.
Trapani, G.et al. “Propofol in Anesthesia. Mechanism of Action, Structure-Activity Relationships, and Drug Delivery” Current Medicinal Chemistry, vol. 7, (2000) p. 249-271.
Trapani, G. et al. “Propofol Analogues. Synthesis, Relationships between Structure and Affinity at GABAA Receptor in Rat Brain, and Differential Electrophysiological Profile at Recombinant Human GABBA Receptors” J Med Chem, vol. 41, (1998), p. 1846-1854.
Adams et al. “Propofol-Induced Injection Pain: Comparison of a Modified Propofol Emulsion to Standard Propofol with Premixed Lidocaine” Anesthesia and Analgesia, vol. 99, (2004), p. 1076-1079.
Baker et al. “Propofol: the challenges of formulation” Anesthesiology, vol. 103, (2005), p. 860-876.
Bocian et al, “Propofol (Diprivan)1—A New Intravenous Anesthetic with Applications for Outpatient Ambulatory Surgery” the journal of foot surgery, vol. 31 (1992) p. 603-606.
Bruce et al. “Oxidative Coupling of Some 2,6-Disubstituted Phenols” Polymer, vol. 10(8), (1969), p. 701-705.
Bryson Harriet M. et al. “Propofol: An Update of its Use in Anaesthesia and Conscious Sedation” Drugs, vol. 60, (1995) p. 613-669.
Doenicke, A.W. et al. “Reducing Pain During Propofol Injection: The Role of the Solvent” Anesth Analg, vol. 82, (1996), p. 472-474.
Doenicke et al. “Pharmacokinetics and Pharmacodynamics of Propofol in a New Solvent” Anesth Analg, vol. 85, (1997), p. 1399-1403.
Dubey, P.K. et al. “Pain on Injection of Lipid-Free Propofol and Propofol Emulsion Containing Medium-Chain Triglyceride: A Comparative study” Anesthesia and Analgesia, vol. 101, (2005), p. 1060-2, table of contents.
Fulton Bret et al. “Propofol: A Pharmacoeconomic Appraisal of its Use in Day Case Surgery” PharmacoEconomics, vol. 9, (1996), p. 168-178.
Fulton Bret et al. “Propofol: An Overview of its Pharmacology and a Review of its Clinical Efficacy in Intensive Care Sedation” Drugs, vol. 50, (1995), p. 636-667.
Gabel, Ronald A. “Sedation/Analgesia—An Anesthesiologist's Perspective” (2002).
Glen, J.B. et al. “Pharmacology of an Emulsion Formulation of ICI 35 868” British Journal of Anaesthesia, vol. 56, (1984), p. 617-626.
Kam, E. et al. “Comparison of Propofol-Lipuro with Propofol Mixed with Lidocaine 10 mg on Propofol Injection Pain” Anaesthesia, vol. 59, (2004), p. 1167-1169.
Kanto J. et al. “Pharmacokinetic Implications for the Clinical Use of Propofol” Clinical Pharmacokinetics, vol. 17, (1989), p. 308-326.
Klement, W. et al “Pain on Injection of Propofol: Effects of Concentration and Diluent” Br J Anaesth, vol. 67, (1991), p. 281-284.
Larijani Ghassem E. et al. “Clinical Pharmacology of Propofol: An Intravenous Anesthetic Agent” DICP The Annals of Pharmacotherapy, vol. 23, (1989), p. 743-749.
Maleck W. H. “Propofol Induced Injection Pain: Comparison of a Modified Propofol Emulsion and Standard Propofol with Premixed Lidocaine” Anesth Analg, vol. 70, (2005), p. 100:1858.
Marinella M.A. “Propofol for Sedation in the Intensive Care Unit: Essentials for the Clinician” Repiratory Medicine, vol. 91, (1997), p. 505-510.
Miller “Effects on the Central Nervous System” Millers Anesthesia, (2005), p. 320-370.
Nathanson, M.H. et al. “Prevention of Pain on Injection of Propofol: A Comparison of Lidocaine with Alfentanil” Anesthesia and Analgesia, vol. 82, (1996), p. 469-471.
Nolan J. et al. “Pharmacokinetic of Propofol Administered by Infusion in Dogs Undergoing Surgery” British Journal of Anaesthesia, vol. 70, (1993), p. 546-551.
Nyman, Y. et al. “Propofol Injection Pain in Children: A Prospective Randomized Double Blind Trial of a New Propofol Formulation Versus Propofol with Added Lidocaine” British Journal of Anaesthesia, vol. 9
Bozicevic Field & Francis LLP
Francis Carol L.
PharmacoFore, Inc.
Tong Connie C.
Witherspoon Sikarl
LandOfFree
Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4269227